Syzygium cumini seed kernel extracts
were evaluated for the inhibition of
![](http://<font color=)
www.sciencedirect.com/scidirimg/entities/204e.gif" alt="greek small letter alpha" title="greek small letter alpha" border="0">-glucosidase from mammalian (rat intestine), bacterial (
Bacillus stearothermophilus), and yeast (
Saccharomyces cerevisiae, baker’s yeast). In vitro studies using the mammalian
![](http://<font color=)
www.sciencedirect.com/scidirimg/entities/204e.gif" alt="greek small letter alpha" title="greek small letter alpha" border="0">-glucosidase from rat intestine sho
wed the extracts to be more effective in inhibiting maltase
when compared to the acarbose control. Since acarbose is inactive against both the bacterial and the yeast enzymes, the extracts
were compared to 1-deoxynojirimycin. We found all extracts to be more potent against
![](http://<font color=)
www.sciencedirect.com/scidirimg/entities/204e.gif" alt="greek small letter alpha" title="greek small letter alpha" border="0">-glucosidase derived from
B. stearothermophilus than that against the enzymes from either baker’s yeast or rat intestine. In an in vivo study using Goto–Kakizaki (GK) rats, the acetone extract
was found to be a potent inhibitor of
![](http://<font color=)
www.sciencedirect.com/scidirimg/entities/204e.gif" alt="greek small letter alpha" title="greek small letter alpha" border="0">-glucosidase hydrolysis of maltose
when compared to untreated control animals. Therefore, these results point to the inhibition of
![](http://<font color=)
www.sciencedirect.com/scidirimg/entities/204e.gif" alt="greek small letter alpha" title="greek small letter alpha" border="0">-glucosidase as a possible mechanism by
which this herb acts as an anti-diabetic agent.